Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

RPHM

Reneo Pharmaceuticals (RPHM)

Reneo Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RPHM
FechaHoraFuenteTítuloSímboloCompañía
13/05/202408:38Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RPHMReneo Pharmaceuticals Inc
13/05/202408:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
13/05/202406:35GlobeNewswire Inc.Reneo Pharmaceuticals and OnKure Announce Proposed MergerNASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202415:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202406:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
28/03/202406:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business UpdateNASDAQ:RPHMReneo Pharmaceuticals Inc
25/03/202406:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:RPHMReneo Pharmaceuticals Inc
05/02/202415:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RPHMReneo Pharmaceuticals Inc
14/12/202308:05GlobeNewswire Inc.Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
21/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202316:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202315:58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202306:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
02/11/202306:50GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:RPHMReneo Pharmaceuticals Inc
25/10/202306:50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific MeetingsNASDAQ:RPHMReneo Pharmaceuticals Inc
09/10/202306:50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
06/10/202307:30GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro SummitNASDAQ:RPHMReneo Pharmaceuticals Inc
29/08/202316:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
28/08/202316:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
10/08/202306:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
30/06/202307:25GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics ForumNASDAQ:RPHMReneo Pharmaceuticals Inc
26/06/202307:25GlobeNewswire Inc.Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® IndicesNASDAQ:RPHMReneo Pharmaceuticals Inc
23/06/202318:12Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:RPHMReneo Pharmaceuticals Inc
15/06/202311:44GlobeNewswire Inc.Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023NASDAQ:RPHMReneo Pharmaceuticals Inc
14/06/202305:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RPHMReneo Pharmaceuticals Inc
08/06/202317:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RPHMReneo Pharmaceuticals Inc
07/06/202315:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RPHMReneo Pharmaceuticals Inc
05/06/202315:08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RPHMReneo Pharmaceuticals Inc
31/05/202309:38GlobeNewswire Inc.Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare ConferenceNASDAQ:RPHMReneo Pharmaceuticals Inc
31/05/202307:00GlobeNewswire Inc.Reneo Pharmaceuticals to Participate at the Jefferies Healthcare ConferenceNASDAQ:RPHMReneo Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RPHM

Su Consulta Reciente

Delayed Upgrade Clock